Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Rheumatology

  • 1
    News

    The evidence is not clear: Rheumatic diseases, drugs, and COVID-19

    August 17, 2020

    Robust is not the word to use when describing the current state of COVID-19 research.

  • 1
    News

    All NSAIDs raise post-MI risk but some are safer than others: Next chapter

    August 5, 2020

    A new cohort analysis extends NSAID cautions in high-CV-risk patients to a Korean population. Some question whether the steep climbs in risk seen for some of the drugs are real.

  • News

    Low vitamin D linked to increased COVID-19 risk

    July 30, 2020

    A large study evaluates associations between low serum vitamin D levels and risks for acquiring COVID-19 and hospitalization.

  • News

    Medical societies advise on vitamin D in midst of COVID-19

    July 13, 2020

    Preliminary results show for the first time that vitamin D intake may be tied to decreased risk for immunotherapy-induced colitis in patients with melanoma.

  • 1
    News

    Even a few days of steroids may be risky, new study suggests

    July 9, 2020

    A retrospective study of more than 2.6 million Taiwanese adults echoes findings from a 2017 cohort study of more than 1.5 million U.S. adults.

  • 1
    News

    ACIP approves flu vaccine recommendations for 2020-2021

    June 25, 2020

    Next season’s vaccination options include new high-dose quadrivalent vaccines for seniors.

  • 1
    News

    ACR issues guidances for MIS-C and pediatric rheumatic disease during pandemic

    June 23, 2020

    The ACR appears to be the first medical organization to review all the most current evidence to issue interim guidance with the expectations that it will change as more data become available.

  • 1
    News

    Entheseal lesions, bone density linked with incident PsA in psoriasis patients

    June 11, 2020

    Metacarpal entheseal lesions and low entheseal bone density in patients with psoriasis each linked with increased incident psoriatic arthritis.

  • 1
    News

    EULAR’s COVID-19 recommendations offer no surprises

    June 11, 2020

    The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and those with the infection, and preventing COVID-19 lookalikes.

  • 1
    News

    Age leads COVID-19 hospitalization risk factors in RMDs

    June 10, 2020

    Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in inflammatory rheumatic diseases.

Previous1 2 3 4 5 6 7Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences